OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: ASU Foundation for A New American University

3 Projects | 2 Researchers | $326,154 Invested

2016

ASU Foundation for A New American University

Travis Dunckley, PhD

Testing of selective DYRK1A inhibitors as a novel treatment for AD - ADD ON

  • Funding Amount: $26,401
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Closed

2015

ASU Foundation for A New American University

Travis Dunckley, PhD

Testing of selective DYRKIA inhibitors as a novel treatment for AD

  • Funding Amount: $224,753
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Closed

2009

ASU Foundation for A New American University

Stephe Johnston, PhD

Immunosignatures: a simple method to potentially diagnose Alzheimer's disease

  • Funding Amount: $75,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed